Clinical Trials Directory

Trials / Unknown

UnknownNCT05300243

The Predictive Role of HPV Integration in HSIL and Cervical Cancer

Status
Unknown
Phase
Study type
Observational
Enrollment
1 (estimated)
Sponsor
Tongji Hospital · Academic / Other
Sex
Female
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

The stratified analysis by the level of HPV DNA integration in HSIL and cervical cancer will be drawn to explore whether the status of HPV integration makes any difference in the progression of cervical cancer. The purpose of the research is to reduce the miss of cervix lesions and prove that HPV integration detection is sensitive in cervical cancer precise screening.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTHPV integration testThe stratified analysis by the level of HPV DNA integration in HSIL and cervical cancer will be drawn to explore whether the status of HPV integration makes any difference in the progression of cervical cancer. The purpose of the research is to reduce the miss of cervix lesions and prove that HPV integration detection is sensitive in cervical cancer precise screening.

Timeline

Start date
2020-07-07
Primary completion
2022-04-01
Completion
2022-06-01
First posted
2022-03-29
Last updated
2022-03-29

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05300243. Inclusion in this directory is not an endorsement.